Surface Oncology, Inc.

SURF · NASDAQ
Analyze with AI
6/30/2023
3/31/2023
12/31/2022
9/30/2022
Assets
Cash & Equivalents$14,842$28,982$50,910$65,096
Short-Term Investments$41,416$73,073$73,913$81,254
Receivables$0$0$0$0
Inventory$0$0-$197$0
Other Curr. Assets$4,330$5,154$4,317$3,772
Total Curr. Assets$60,588$107,209$129,140$150,122
Property Plant & Equip (Net)$5,418$28,204$29,173$29,813
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$1,595$1,597$1,686
Total NC Assets$5,418$29,799$30,770$31,499
Other Assets$0$0$0$0
Total Assets$66,006$137,008$159,910$181,621
Liabilities
Payables$609$1,108$256$535
Short-Term Debt$9,488$5,811$5,790$5,757
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$6,731$7,831$10,214$11,700
Total Curr. Liab.$16,828$14,750$16,260$17,992
LT Debt$0$46,427$50,247$50,810
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$46,427$50,247$50,810
Other Liabilities$0$0$0$0
Cap. Leases$9,488$29,750$30,452$31,105
Total Liabilities$16,828$61,177$66,507$68,802
Equity
Pref Stock$0$0$0$0
Common Stock$6$6$6$6
Retained Earnings-$252,262-$224,070-$204,329-$182,997
AOCI-$221-$569-$1,015-$1,369
Other Equity$301,655$300,464$297,726$297,179
Total Equity$49,178$75,831$93,403$112,819
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$66,006$137,008$159,910$181,621
Net Debt-$5,354$23,256$5,127-$8,529